Jefferson Radiation Oncology at Riddle

The Jefferson Radiation Oncology Center at Riddle, located on the Ground Floor of Health Care Center I, is one of several Jefferson radiation oncology program sites located throughout the Delaware Valley. The center provides the most advanced radiation oncology treatment options. As part of the Department of Radiation Oncology at Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson, Radiation Oncology at Riddle offers the same quality services available at Jefferson's Center City facility.

Radiation Oncology

This unit is staffed with physicians from Thomas Jefferson University Hospital who deliver the same high quality care here as they offer at their facility in Philadelphia. The Center contains a state-of-the-art linear accelerator capable of generating a wide range of x-ray and electron energies to optimize treatment. Riddle patients can receive treatment by 3-Dimensional conformal Radiation Therapy ( 3-D CRT ), Intensity Modulated Radiation Therapy ( IMRT ), and implant brachytherapy depending on their individual treatment needs.

Videoconferencing

This system enables physician interaction among cancer specialists at Thomas Jefferson University Hospital and Riddle Memorial Hospital. These telemedical consultations ensure that the most advanced knowledge about cancer treatment, clinical trials and outcome data can be instantaneously shared.

Risk Assessment/Genetic Counseling

The Jefferson Hereditary Cancer Center is dedicated to identifying and managing individuals with a known or suspected inherited pre-disposition to cancer.

Clinical Trials

Riddle Hospital is part of the Jefferson Cancer Network. As part of the Network, Riddle's patients have access to the latest National Cancer Institute (NCI) and Jefferson protocols for cancer. Jefferson is also directly involved in clinical trials and cancer prevention activities through full membership in the Radiation Therapy Oncology Group (RTOG), a national cancer research organization sponsored and funded by the NCI, and affiliation with the Eastern Cooperative Oncology Group (ECOG), another National Cancer Institute (NCI)-supported organization working to improve outcomes for cancer patients nationwide.